17 Aug 2017 | 12:18 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
782.00
16.30
(2.13 %)
17 Aug 2017 | 12:04 PM
Change company
  • Open (Rs)
    770.00
  • Prev. close (Rs.)
    765.70
  • High (Rs.)
    786.95
  • Low (Rs.)
    765.35
  • 52W H (Rs.)
    1,080.00
  • 52W L (Rs.)
    495.00
  • Volume (Rs.)
    26091
  • MCap (Rs in Cr.)
    13,630.89
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
8.91
Operating Margin (%)
23.62
Gross Profit Margin (%)
19.16
Net Profit Margin (%)
13.59
Total Debt/Equity
0.08
Dividend payout Ratio (Net Profit)
16.88
Earning Retention Ratio
83.49

News

14 Aug 2017 - 16:25:00-Natco Pharma said that it has received the final approval of Abbreviated New Drug Application (ANDA)...
07 Aug 2017 - 17:13:00-Drug maker Natco Pharma has reported standalone net profit of Rs 97...
20 Jul 2017 - 11:36:00-Drug maker Natco Pharma said that it has received successful Establishment Inspection Report (EIR) f...
27 Jun 2017 - 15:49:00-Drug maker Natco Pharma Ltd on Tuesday said it has received final approval of ANDA from the US healt...

Announcements

14-Aug-2017
Natco Pharma - Investor Presentation
14-Aug-2017
Natco Pharma - Investor Presentation
14-Aug-2017
Natco Pharma - Press Release
14-Aug-2017
Natco Pharma - Press Release / Media Release
07-Aug-2017
Natco Pharma - Board declares Interim Dividend (AGM on Sept 23 2017)

Religare Research

17 Aug 2017 | 09:31 AM
• Gold edges up after gaining on softer dollar • Oil dipped despite steep draw in U.S. crude stocks ...
17 Aug 2017 | 07:00 AM
We feel Nifty will spend some time in a range before any major directional move. It should hold abov...
16 Aug 2017 | 10:23 AM
Gold falls on strong dollar after U.S. data, easing North Korea tensions Oil prices edge up on falli...
16 Aug 2017 | 10:21 AM
The Indian rupee ended little changed against the dollar amid thin trade, as foreign banks bought th...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 32.16 1.04
4,00,000 90.05 135.91 1.02
4,00,000 90.05 142.22 1.02
4,00,000 90.05 51.75 1.02
1,60,000 35.89 90.58 1.50

Shareholding Pattern

       
Promotors51.24%
Mutual Funds/UTI5.01%
FI/Banks2.28%
Insurance2.28%
FII19.41%
Government0.00%
Others3.38%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,742.30(-0.04)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,379.90(0.63)
3317
 Dr. Reddy`s Laboratories Ltd.
2,010.90(0.61)
3294
 Alkem Laboratories Ltd.
1,838.90(1.54)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.-192.90-166.4515.55
NIFTY(S&P CNX)74.15389.051,123.30
BSE SENSEX-295.111,197.073,478.40
BSE 500106.48414.991,681.88

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
Natco House Road No.2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Natco Pharma Ltd. that will help you decide whether to buy, sell or hold Natco Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Natco Pharma Ltd.